Otsuka Holdings Co., Ltd. (FRA:OS1)

Germany flag Germany · Delayed Price · Currency is EUR
42.20
-0.40 (-0.94%)
At close: Jun 4, 2025, 10:00 PM CET
8.76%
Market Cap 21.69B
Revenue (ttm) 14.79B
Net Income (ttm) 2.17B
Shares Out n/a
EPS (ttm) 4.01
PE Ratio 10.01
Forward PE n/a
Dividend 0.71 (1.69%)
Ex-Dividend Date Dec 27, 2024
Volume n/a
Average Volume 37
Open 42.20
Previous Close 42.60
Day's Range 42.20 - 42.20
52-Week Range 36.20 - 59.00
Beta n/a
RSI 48.63
Earnings Date Jul 31, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr... [Read more]

Industry Pharmaceutical Preparations
Founded 1921
Employees 35,338
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol OS1
Full Company Profile

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.

Financial numbers in JPY Financial Statements

News

There is no news available yet.